The prevalence and significance of chronic obstructive pulmonary disease in subjects with acute coronary syndrome
- Conditions
- Chronic obstructive pulmonary disease, acute coronary syndromeRespiratoryChronic obstructive pulmonary diseaseAcute ischaemic heart disease, unspecified
- Registration Number
- ISRCTN05697808
- Lead Sponsor
- Jämtland County Council (Sweden)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 350
1. All patients living in the county of Jämtland, Sweden, and hospitalised with a diagnosis of myocardial infarction or unstable angina will be assessed for inclusion
2. Östersund hospital is the only hospital in the county and all patients, terminal care excluded, with symptoms of a suspected acute coronary syndrome are referred for diagnostic evaluation
3. Study subjects are recruited in conjunction with the study Secondary preventive, nurse based, telephone follow-up for risk factor control after an acute coronary syndrome (http://www.isrctn.com/ISRCTN96595458/)
1. Dementia
2. Patients with severe disease
3. Subjects unable to perform adequate spirometry
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. The prevalence of spirometry-verified COPD versus medical-record based COPD in subjects with ACS<br>2. The adjusted hazard ratio of spirometry-verified COPD for death, reinfarction and stroke in subjects with ACS. Adjustment for age, gender, renal function, C-reactive protein, Killip class, previous myocardial infarction (MI), atrial fibrillation, coronary intervention, secondary preventive medication, diabetes, and smoking history.
- Secondary Outcome Measures
Name Time Method In subjects with ACS, spirometry-verified COPD is an independent predictor of hospital admissions (due to coronary angiography, percutaneous coronary intervention, coronary artery bypass surgery, angina, heart failure) and length of hospital stay.